While many people lose more weight on tirzepatide, individual results vary, and effectiveness depends on dosing, lifestyle changes, and consistency
Different rules in each country, supply issues, and safety concerns can make it challenging to determine the best course of action
While not yet approved for general use, its potential for weight loss, energy, and metabolic health makes it a focus of ongoing research.
Further reading: Wegovy tablets results Based on the current published figures, Wegovy tablets appear to deliver greater average weight loss
Replacement of the GLP-2 middle region (residues 719) that mainly interacts with TM1, TM7 and ECL1 by the corresponding part of GLP-1, almost abolished GLP-2R-mediated cAMP accumulation but fully rescued that induced by GLP-1R (Fig